IL17A and neoplasm: Immunofluorescent analysis indicated strong immunoreactivity of tumor cells, Brunner's glands, and the tumor stroma for both cytokines and downstream pSTAT3 activation.149 Both IL-17 and TNF⍺ are known to activate downstream targets through NF-κB and pSTAT3 signaling pathways.